Separate regulations needed for medical devices: AdvaMed

Image
Press Trust of India New Delhi
Last Updated : Oct 19 2014 | 11:07 AM IST
Medical devices sector in India needs to be regulated in harmonisation with international practises and should to be treated as separate from 'drugs', trade association AdvaMed has said.
"There should be a separate regulatory agency for the medical devices with adequate trained personnel. Indian medical devices regulation should be harmonised with the guidelines of Global Harmonisation Task Force (GHTF)," AdvaMed Vice President Abby Pratt told PTI.
AdvaMed is an association of medical devices makers representing 80 per cent of medical technology firms in the US and its member companies produce more than 40 percent of medical devices used annually around the world.
Pratt said given the significant differences between pharmaceuticals and medical devices, applying the same regulatory and pricing systems for medical devices could reduce the ability for Indian manufacturers to grow.
"In India the disease burden is transitioning from communicable diseases to non-communicable diseases like cancer, diabetes and heart disease and it increases the role of medical technology," she said.
Currently only few categories of medical devices are being
regulated by the regulatory body and that too as 'drugs' under the Drugs and Cosmetics Act, so it is important that Drugs and Cosmetics (Amendment) Bill 2013 should be passed, she added.
Highlighting the significance of medical devices sector and it's tremendous growth potentials Pratt said: "It is valued at USD 4 billion (in India) at present but it is a very important part of the healthcare."
The ecosystem for growth has be developed so that the sector can realise its tremendous potential to solve India's healthcare problems, she added.
*Subscribe to Business Standard digital and get complimentary access to The New York Times

Smart Quarterly

₹900

3 Months

₹300/Month

SAVE 25%

Smart Essential

₹2,700

1 Year

₹225/Month

SAVE 46%
*Complimentary New York Times access for the 2nd year will be given after 12 months

Super Saver

₹3,900

2 Years

₹162/Month

Subscribe

Renews automatically, cancel anytime

Here’s what’s included in our digital subscription plans

Exclusive premium stories online

  • Over 30 premium stories daily, handpicked by our editors

Complimentary Access to The New York Times

  • News, Games, Cooking, Audio, Wirecutter & The Athletic

Business Standard Epaper

  • Digital replica of our daily newspaper — with options to read, save, and share

Curated Newsletters

  • Insights on markets, finance, politics, tech, and more delivered to your inbox

Market Analysis & Investment Insights

  • In-depth market analysis & insights with access to The Smart Investor

Archives

  • Repository of articles and publications dating back to 1997

Ad-free Reading

  • Uninterrupted reading experience with no advertisements

Seamless Access Across All Devices

  • Access Business Standard across devices — mobile, tablet, or PC, via web or app

More From This Section

First Published: Oct 19 2014 | 11:07 AM IST

Next Story